MedTrace Logo

CBT With Disulfiram and Contingency Management

NCT00350870 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 181

Last updated 2014-12-03

Study results available
· View outcomes & findings →

Summary

This is a study of four treatments for chronic cocaine use and may help study participants to control their drug use. All participants will receive weekly individual cognitive behavioral therapy (CBT).

Conditions

  • Cocaine Abuse

Interventions

DRUG

disulfiram

250mg per day of Disulfiram plus CBT

DRUG

Placebo

Placebo plus CBT

BEHAVIORAL

Placebo plus Contingency Management

Placebo plus Contingency Management for cocaine abstinence and medication compliance in addition to CBT

DRUG

Disulfiram plus Contingency Management

250mg of Disulfiram plus Contingency Management for cocaine abstinence and medication compliance plus CBT.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Kathleen M. Carroll, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00350870 on ClinicalTrials.gov